tickrz reports
tickrz rank
D
CME Group Inc (CME)
Financial | Financial Services
131.81  0.39%
FACTOR RANKINGSFACTOR SCREENER 
tickrz RankD / 384Warren Buffett RankD / 404
Pure Value RankC / 344Dividend RankD / 426
Moat RankD / 449Financial Strength RankN/A
Growth RankD / 376Momentum RankB / 237
CME vs FINANCIAL SERVICES SECTOR & S&P 500
VALUATION
CMESECTORS&P 500
P/E RATIO26.8723.719.28
EV/EBITDA RATIO18.2821.911.77
P/S RATIO12.377.22.03
P/B RATIO2.153.93.09
QUALITY
RETURN ON EQUITY7.94%11.29%13.82%
RETURN ON CAPITAL6.55%7.98%10.04%
NET MARGIN41.56%19.98%9.76%
DIVIDEND ANALYSIS
DIVIDEND YIELD
1.92%
PAYOUT RATIO117.44%
3 YR DIVIDEND GROWTH10.06%
FINANCIAL STRENGTH
F SCORE NOT AVAILABLE
DEBT-TO-EQUITY11%
INTEREST COVERAGE19.21x
CURRENT RATIO
GROWTH
5 YR EPS GROWTH-3.56%
5 YR SPS GROWTH2.39%
5 YR BPS GROWTH-1.6%
About tickrz
Key Concepts
Great Investors
tickrz Report
tickrz rank D / 384
CME Group Inc receives a D ranking in our proprietary ranking system that combines valuation, moat, operational performance, and financial strength. View the Top 50 tickrz ranked stocks here.
value
pure value ranking C / 344Warren Buffett ranking D / 404
Valuation is the most heavily weighted component in our tickrz ranking methodology. Numerous academic and practitioner studies have found that a value approach outperforms the market over the long-run. CME Group Inc's valuation score is comprised of a P/E ratio of 26.9x, a P/B ratio of 2.2x, a P/S ratio of 12.4x, and an EV/EBITDA ratio of 18.3x. CME Group Inc ranks 344 out of the S&P 500 constituents on valuation--a relatively weak score.CME Group Inc ranks 404 out of the S&P 500 constituents in our multi-factor Warren Buffett ranking methodology. This is a weak score, meaning it ranks poorly on valuation, moat, volatility, and financial strength factors. If you're looking for undervalued stocks with high moats and strong competitive advantages, CME Group Inc is probably not for you.

quality
moat D / 449financial strength N/A
To calculate a company's Moat Score, we look at its historical earnings growth, historical average return on equity, the volatility of its earnings stream, and also factor in the strength of its balance sheet. Our approach concludes the company's business moat is weak. Its position within the Financial sector appears to be weak. Either the dynamics of its sector place it in a difficult position or management's executition is to blame for its disappointing performance. Interest coverage of 19.21x, a debt/equity ratio of 11% and a Moat Rank of 449 translate to a not available Financial Strength score.


momentum B / 237
Investment research has shown that stocks with strong performance over the last 6 to 12 months tend to perform better in the medium term than stocks with poor performance over the same period. In fact, the momentum factor is one of the strongest of all the investment factors. The company has seen its stock appreciate by 15.23% over the last 12 months. This performance is average compared to other stocks in the S&P 500, earning it a rank of 237. Based on its 12 month stock performance, CME Group Inc will not appeal to momentum investors.

yield D / 426
value + yield
Shares currently yield 1.92%. Our dividend ranking approach looks at a company's dividend growth rate, payout ratio, business moat, and valuation. Based on our methodology, CME Group Inc ranks 426 among the S&P 500 constituents. Investors looking for undervalued dividend stocks will probably want to look elsewhere.

growth D / 376
A company's growth metrics are less important than its valuation, moat, and financial strength. However, a check on growth can be a good way to avoid companies in secular decline. The company's growth in sales, earnings, and book value places it among the bottom third of S&P500 companies. Its -3.6% 5 year annualized EPS growth, 2.4% 5 year annualized sales-per-share growth, and 5 year annualized book value-per-share growth of -1.6% speak to its relatively poor ranking.

CME Group Inc (CME)
Financial | Financial Services
131.81  0.39%


tickrz rank
D
VALUATION RATIOS
P/E Ratio26.87x
P/B Ratio2.15x
P/S Ratio12.37x
EV/EBITDA Ratio18.28x
DIVIDEND ANALYSIS
DIVIDEND YIELD
1.92%
PAYOUT RATIO117.44%
3 YR DIVIDEND GROWTH10.06%
FINANCIAL STRENGTH
F SCORE NOT AVAILABLE
DEBT-TO-EQUITY11%
INTEREST COVERAGE19.21x
CURRENT RATIO
MOAT
ROE7.94%
ROIC6.55%
Net Margin41.56%
GROWTH
5 YR EPS GROWTH-3.56%
5 YR SPS GROWTH2.39%
5 YR BPS GROWTH-1.6%

TICKRZ RANK
CME Group Inc receives a D ranking in our proprietary ranking system that combines valuation, moat, operational performance, and financial strength. View the Top 50 tickrz ranked stocks here.

PURE VALUE
Valuation is the most heavily weighted component in our tickrz ranking methodology. Numerous academic and practitioner studies have found that a value approach outperforms the market over the long-run. CME Group Inc's valuation score is comprised of a P/E ratio of 26.9x, a P/B ratio of 2.2x, a P/S ratio of 12.4x, and an EV/EBITDA ratio of 18.3x. CME Group Inc ranks 344 out of the S&P 500 constituents on valuation--a relatively weak score.

WARREN BUFFETT RANKING
CME Group Inc ranks 404 out of the S&P 500 constituents in our multi-factor Warren Buffett ranking methodology. This is a weak score, meaning it ranks poorly on valuation, moat, volatility, and financial strength factors. If you're looking for undervalued stocks with high moats and strong competitive advantages, CME Group Inc is probably not for you.

MOAT
To calculate a company's Moat Score, we look at its historical earnings growth, historical average return on equity, the volatility of its earnings stream, and also factor in the strength of its balance sheet. Our approach concludes the company's business moat is weak. Its position within the Financial sector appears to be weak. Either the dynamics of its sector place it in a difficult position or management's executition is to blame for its disappointing performance.

FINANCIAL STRENGTH
Interest coverage of 19.21x, a debt/equity ratio of 11% and a Moat Rank of 449 translate to a not available Financial Strength score.

MOMENTUM
Investment research has shown that stocks with strong performance over the last 6 to 12 months tend to perform better in the medium term than stocks with poor performance over the same period. In fact, the momentum factor is one of the strongest of all the investment factors. The company has seen its stock appreciate by 15.23% over the last 12 months. This performance is average compared to other stocks in the S&P 500, earning it a rank of 237. Based on its 12 month stock performance, CME Group Inc will not appeal to momentum investors.

VALUE + YIELD
Shares currently yield 1.92%. Our dividend ranking approach looks at a company's dividend growth rate, payout ratio, business moat, and valuation. Based on our methodology, CME Group Inc ranks 426 among the S&P 500 constituents. Investors looking for undervalued dividend stocks will probably want to look elsewhere.

GROWTH
A company's growth metrics are less important than its valuation, moat, and financial strength. However, a check on growth can be a good way to avoid companies in secular decline. The company's growth in sales, earnings, and book value places it among the bottom third of S&P500 companies. Its -3.6% 5 year annualized EPS growth, 2.4% 5 year annualized sales-per-share growth, and 5 year annualized book value-per-share growth of -1.6% speak to its relatively poor ranking.